About
Lars is CEO of Engimmune Therapeutics and brings more than 20 years of leadership experience in the development of several pharmaceutical products and innovative technologies. Previously, Lars was Chief Technology Officer at Nordic Nanovector, VP and Strategic Product Lead at Bayer and held several leadership roles at F. Hoffmann-La Roche responsible for clinical supply planning, biologics technology and technical business development biologics. Lars gained his PhD from the Max-Planck-Institute for Biochemistry, Munich, and Institute for Biochemistry at the University of Zürich; he also holds an executive MBA from the University of St. Gallen, Switzerland.
Sign up to see Dr. Lars Nieba's full profile
Access investment thesis, focus areas, bio, and contact details for Dr. Lars Nieba and 22,000+ other VC professionals.
Pureos Bioventures
Pfäffikon, CH